e14566 Background: Esophageal squamous cell carcinoma (ESCC) has been generally considered as one of the most aggressive cancers with poor prognosis. Vimentin has been regarded as a marker of epithelial-mesenchymal transition (EMT). However, little is known about ESCC with vimentin expression as a marker of EMT. In this study, we analyzed vimentin expression of ESCC and its aggressive behavior. Methods: One hundred and twenty-nine ESCC were surgically resected at Hirosaki University Hospital from 1996 to 2008. All the patients underwent operations including subtotal esophagectomy and dissection of lymph nodes. No patients received radiotherapy or chemotherapy before operation. In each patient, one representative histological specimen at the deepest invaded area of an esophageal cancer lesion was selected, and immunohistochemical examination of Vimentin and α-smooth muscle actine (α-SMA) was performed. In addition, in cases of lymph node metastasis, the largest metastatic carcinoma specimen was selected, and the same immunohistochemical examination of vimentin was performed. Results: Vimentin expression was identified in 96 of the 129 cases (74.4%). The cases with vimentin-positive carcinoma cells showed a significantly higher incidence of lymph node metastasis (P=0.001). Carcinomas with vimentin expression were more advanced in terms of tumor status and lymphatic invasion (P=0.001, P=0.009, respectively), and associated with stronger stromal α-SMA expression (P<0.001). Vimentin expression was also associated with distant metastasis, including distant node metastasis (P=0.014). Vimentin expression in both primary and metastatic carcinomas was found in 68.6% (48/70) of the cases, while no vimentin expression in both primary and metastatic carcinomas comprised 92.3% of the cases (12/13) (P<0.001). Finally, Vimentin expression in ESCC is an independent predictor of lymph node metastasis (multivariate analysis, P=0.014, odds ratio: 3.314, 95% confidence interval: 1.276-8.605). Conclusions: Vimentin expression in ESCC is an independent predictor of lymph node metastasis. In addition, vimentin expression was frequently retained in metastatic carcinoma of the lymph node.